447 filings
Page 2 of 23
6-K
sneljn
2 Dec 21
Current report (foreign)
12:00am
6-K
xvb pjmjqlzw8jq
30 Nov 21
Addition to the agenda of the Annual General Meeting on 14 December 2021 pursuant to section 122 (2) AktG at the request of a shareholder
12:21pm
SC 13D/A
8lizb
29 Nov 21
Biofrontera / DEUTSCHE BALATON AKTIENGESELLSCHAFT ownership change
4:01pm
6-K
8kgqnojm np
29 Nov 21
Current report (foreign)
1:13pm
6-K
myevx 0lkp5omvb3
29 Nov 21
Current report (foreign)
10:23am
6-K
tx08lq4dqgk1
24 Nov 21
Invitation to the Annual General Meeting
10:12am
6-K
9jnubwe5 0pw1
19 Nov 21
Biofrontera AG announces mediation results
11:02am
6-K
6hhbpzo5bkwexhuv5eq
18 Nov 21
Quarterly report Q3 2021
12:00am
6-K
ctmvw8o0p4hd30p8eu
16 Nov 21
Biofrontera AG announces initiation of clinical studies
11:40am
6-K
xzkwu40gbd99di kg
10 Nov 21
Current report (foreign)
9:28am
6-K
0qt09
9 Nov 21
Current report (foreign)
10:29am
6-K
hbue44gko 8yprtecldb
3 Nov 21
Current report (foreign)
12:13pm
6-K
ryojgp3vi2ustx9raqtj
2 Nov 21
Current report (foreign)
4:47pm
6-K
rb3ke0
2 Nov 21
Current report (foreign)
3:41pm
6-K
gy7jxr9
29 Oct 21
Current report (foreign)
6:07am
3
kwcm1kwi1
28 Oct 21
Biofrontera / AG Biofrontera ownership change
9:46pm
6-K
uysj x1ha3
28 Oct 21
Current report (foreign)
12:00am
6-K
vt5dj1yp66
22 Oct 21
Biofrontera AG receives FDA-approval of the BF-RhodoLEDĀ® XL lamp
12:34pm
6-K
ygmshuf
1 Oct 21
Current report (foreign)
10:16am
6-K
3bjwr7
1 Oct 21
Biofrontera reports preliminary approximate revenues for the month of September 2021
10:10am